Investigation of the AgNOR (Argyrophilic Nucleolar Organizing Region) Protein Levels in Patients with Coronary Artery Diseases The Prognostic Role of AgNOR Proteins in Acute Myocardial Infarction
Article Sidebar
Main Article Content
Abstract
Objective: This study aimed to evaluate the prognostic significance of Argyrophilic Nucleolar Organizing Region (AgNOR) proteins in patients with acute myocardial infarction (AMI) and to determine their potential role in predicting the extent of myocardial damage.
Materials and Methods: A case-control study was conducted with 20 AMI patients and 17 healthy controls. Peripheral blood samples were stained to assess AgNOR protein levels. The AgNOR parameters, such as the number of AgNORs and the total AgNOR area to total nuclear area (TAA/NA) ratio, were analyzed using ImageJ software. Statistical analyses were performed using SPSS to assess differences between groups and correlations with clinical markers.
Results: The study revealed a significant increase in both the mean AgNOR number and TAA/NA ratio among AMI patients compared to controls (p < 0.01). These parameters also correlated with known cardiac damage markers such as Troponin I level. Sensitivity (100%) and specificity (100%) analysis indicated that these AgNOR parameters could effectively differentiate between AMI patients and healthy individuals.
Conclusion: AgNOR proteins emerge as a promising and dependable biomarker for evaluating myocardial damage and predicting patient prognosis in cases of AMI. Their remarkable sensitivity and specificity in distinguishing AMI cases underscore their potential clinical utility. However, further studies with larger cohorts are imperative to validate these findings.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-11-21
Published 2023-11-24
References
Saritas A, Gunes H, Colakoglu S, Eroz R, Akoz A, Oktay M, et al. Are there any effects of chronic carbon monoxide exposure on argyrophilic nucleolar-organizing region–associated protein synthesis in rat myocardium? Human & Experimental Toxicology. 2016;35(9):921-8.
Mamaev N, Kovalyeva O, Amineva KK, AYa G, YuB M, Polykarpov I, et al. AgNORs in cardiomyocytes from surgical patients with coronary heart disease. Molecular Pathology. 1998;51(4):218.
Turan Sönmez F, Eröz R. The role of argyrophilic nucleolar organizing region-associated proteins in clinical exacerbation of chronic obstructive pulmonary disease. Journal of International Medical Research. 2018;46(12):4995-5003.
Köksal M, Doğan S, Eroz R, Öztürk F, Öztürk A, Cücer N. Comparative Evaluation of Argyrophilic Nucleolar Organizer Regions Parameters in Benign and Malignant Breast Tumors. 2023.
Damar İH, Recep E. May Argyrophilic Nucleolar Organizer Regions be the New Marker of a Hypoxic Response in Non ST Elevation Myocardial Infarction? Konuralp Medical Journal.14(1):132-41.
Damar İH, Eroz R. Argyrophilic nucleolar organizer regions as new biomarkers in ST-Elevation myocardial infarction. Journal of Cardiovascular Development and Disease. 2022;9(2):58.
Lindner LE. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). Journal of Histochemistry & Cytochemistry. 1993;41(3):439-45.
Benn P. Chromosome staining and banding techniques. Human Cytogenetics: a practical approach. 1986:57-84.
Rasband W. US National Institutes of Health. http://imagej nih gov/ij/. 2011.
Kandiş H, Afacan M, Eröz R, Colakoglu S, Bayramoglu A, Oktay M, et al. Can argyrophilic nucleolar organizing region-associated protein amount be used for the detection of cardiac damage? Human & experimental toxicology. 2016;35(3):323-31.
Yesildag K, Kokulu K, Mutlu H, Eroz R, Taha-Sert E, Saritas A. Argyrophilic nucleolar organizer regions as a promising biomarker for the detection of brain hypoxia levels caused by different doses of carbon monoxide poisoning. Gaceta médica de México. 2021;157(6):630-7.
Ozbay S, Ayan M, Eroz R, Saritas A. Detection of Brain Tissue Damage in CO Poisoning with a New Method. 2023.
Shlyakhto E, Bokeria L, Gudkova A, Borisov K, Rybakova M, Chekanov P, et al. 82 Estimation of AgNOR proteins expression, degree of polyploidy and cardiomyocite nuclei morphometry in patients with obstructive hypertrophic cardiomyopathy. European Journal of Heart Failure Supplements. 2004;3:20-1.
Bestetti R, Assad T, Carvalho G, Villafanha D. 79 Clinical course of patients with end-stage Chagas' cardiomyopathy on the waiting list for heart transplantation. European journal of heart failure Supplement. 2004;3(1):20-.